KEAP1 and type 2 diabetes mellitus: In type 2 diabetes, improving the nuclear factor erythroid 2–related factor 2 (Nrf2)/kelch like ECH‐associated protein 1 (Keap1)/antioxidant response element signaling pathway mediates antioxidant defense, inhibits inflammation, and promotes cell survival; thus, it may attenuate oxidative damage (David et al., 2017).